1. Officials expect 20 million Americans to be vaccinated for COVID-19 by December  Good Morning America
  2. Moderna to charge $25-$37 for Covid-19 vaccine: CEO  Times of India
  3. Two more Covid-19 hospital deaths confirmed in Devon  Devon Live
  4. Moderna to charge Rs 1855-Rs 2755 per dose for COVID-19 vaccine, says CEO  DNA India
  5. 'I am just blown away': Small business owner evicted from Summit Mall after 3 months of closure due to COVID-19  News 5 Cleveland
  6. View Full coverage on Google News
Science News: Moderna will charge governments between $25 and $37 per dose of its Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive StephScience News: Moderna will charge governments between $25 and $37 per dose of its Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive Steph

Corona vaccine news: Moderna to charge $25-$37 for Covid-19 vaccine: CEO | - Times of India

There have no been 38,112 people who have died in hospitals in England since testing positive for coronavirusThere have no been 38,112 people who have died in hospitals in England since testing positive for coronavirus

Two more Covid-19 hospital deaths confirmed in Devon - Devon Live

Moderna to charge Rs 1855-Rs 2755 per dose for COVID-19 vaccine, says CEO - The CEO said that the price of the coronavirus vaccine will depend on the number of doses ordered by the governments.Moderna to charge Rs 1855-Rs 2755 per dose for COVID-19 vaccine, says CEO - The CEO said that the price of the coronavirus vaccine will depend on the number of doses ordered by the governments.

Moderna to charge Rs 1855-Rs 2755 per dose for COVID-19 vaccine, says CEO

Serum Institute of India's CEO Adar Poonawalla said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public.Serum Institute of India's CEO Adar Poonawalla said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public.

2 Doses of Oxford Covid-19 Vaccine to Cost Maximum Rs 1,000, Says Serum Institute CEO Adar Poonawalla

Covishield will be available for the rest of the public by March-April 2021, SII CEO, Adar Poonawalla said at the HT leadership summit. The vaccine which can be stored at temperatures between 2°C and 8°C could cost between Rs 500 and 600, he also said.Covishield will be available for the rest of the public by March-April 2021, SII CEO, Adar Poonawalla said at the HT leadership summit. The vaccine which can be stored at temperatures between 2°C and 8°C could cost between Rs 500 and 600, he also said.

Covishield for COVID-19 could cost Rs 500: Serum CEO - Oneindia News

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals.Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals. Probably by 2024, every Indian will get vaccinated, he said at the Hindustan Times Leadership Summit (HTLS), 2020.

COVID-19 vaccine should be available for all by April 2021: Serum Institute CEO | The News Minute

Summit Mall cafe owner evicted.Summit Mall cafe owner evicted.

'I am just blown away': Small business owner evicted from Summit Mall after 3 months of closure due to COVID-19

Hindustan TimesSII CEO and owner Adar Poonawalla spoke on preparation for future pandemics. Speaking at Hindustan Times Leadership Summit, Poonawalla said that instead of reinventing the wheel with new technology to deal with a disease, we should rely on proven technology platforms. In a...Hindustan TimesSII CEO and owner Adar Poonawalla spoke on preparation for future pandemics. Speaking at Hindustan Times Leadership Summit, Poonawalla said that instead of reinventing the wheel with new technology to deal with a disease, we should rely on proven technology platforms. In a conversation with Sanchita Sharma, health editor, HT, Poonawalla said that SII plans to launch a new vaccine every 4-5 months. Watch the full video for more.

How can we prepare for future pandemics? Adar Poonawalla answers at #HTLS2020 - htls - videos - Hindustan Times

Get a fresh dose of the news that matters delivered directly to your inbox, every morning. The perfect way to get you started and informed for the day ahead.Get a fresh dose of the news that matters delivered directly to your inbox, every morning. The perfect way to get you started and informed for the day ahead.

News18 Daybreak | Covid-19 Vaccine to Cost Max Rs 1,000, Says Serum Institute CEO, Ahmedabad to Impose Total Weekend Curfew as Infections Increase and Other Stories You Need to Watch Out For

Adar Poonawalla set out to double the capacity of Serum Institute of India (SII) way back in 2011 and today it is the world’s largest vaccine manufacturer by volume.  At the 18th Hindustan Times Leadership Summit on November 19, Poonawalla said that he began to focus on creating mass capacity for a pandemic after he took over as the CEO of SII. Adar Poonawalla set out to double the capacity of Serum Institute of India (SII) way back in 2011 and today it is the world’s largest vaccine manufacturer by volume.  At the 18th Hindustan Times

Serum Institute of India decided to bet early on Covid-19 vaccine to save lives: Adar Poonawalla | Deccan Herald

Poonawalla says Serum Institute plans to apply for an emergency use authorization from Drug Controller General of India V.G. Somani for the vaccine next month, and get the regulatory green light in JanuaryPoonawalla says Serum Institute plans to apply for an emergency use authorization from Drug Controller General of India V.G. Somani for the vaccine next month, and get the regulatory green light in January

Serum may sell Oxford vaccine at ₹600 per dose in pharmacies

Coronavirus vaccine price: Covishield is the name in India of the Covid-19 vaccine candidate developed by the University of Oxford and AstraZeneca. Promising results about the effectiveness of the candidate in vulnerable age groups were published in The Lancet on Thursday.Coronavirus vaccine price: Covishield is the name in India of the Covid-19 vaccine candidate developed by the University of Oxford and AstraZeneca. Promising results about the effectiveness of the candidate in vulnerable age groups were published in The Lancet on Thursday.

Coronavirus vaccine may cost Rs 500-600: Serum CEO

The pandemic Covid-19 has caused a huge devastation across the globe. So far 56 million people got infected of the virus while 1.3 million have died. ManyThe pandemic Covid-19 has caused a huge devastation across the globe. So far 56 million people got infected of the virus while 1.3 million have died. Many

Covid Vaccine @ Rs 1000 - Gulte

Tune in to Coronavirus Essential podcast for news on the pandemic.Tune in to Coronavirus Essential podcast for news on the pandemic.

Coronavirus Essential podcast | Oxford vaccine to be priced at Rs 500 per dose in India; Pfizer to seek emergency use approval in US

Poonawalla said that the government will get this vaccine and at a lower price ($3 to $4 i.e. 225-300 rupees) because it will buy a lot of doses.Poonawalla said that the government will get this vaccine and at a lower price ($3 to $4 i.e. 225-300 rupees) because it will buy a lot of doses.

Here's For How Much You Will Get Dose of Covishield Vaccine According To Adar Poonawalla | HW English

Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to apply for an emergency approval from the Indian government next month for using the coronavirus vaccine on corona warriors and the elderly, as they are at high-risk. | NewsBytesPune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to apply for an emergency approval from the Indian government next month for using the coronavirus vaccine on corona warriors and the elderly, as they are at high-risk. | NewsBytes

Oxford vaccine to be available by April 2021 in India | NewsBytes

SII to make about 10 crore doses per month from February, 30-40 crore doses of the vaccine will be available by the first quarter of 2021

Covishield should be available for public by April 2021: Adar Poonawalla - Express Pharma

Oxford coronavirus vaccine should be available for the healthcare workers and elderly people by around February 2021 and by April for the general public, Serum Institute of India CEO Adar Poonawalla has said.Oxford coronavirus vaccine should be available for the healthcare workers and elderly people by around February 2021 and by April for the general public, Serum Institute of India CEO Adar Poonawalla has said.

Coronavirus vaccine should be available for public by April 2021: Serum Institute CEO - Coronavirus Outbreak News

"It will be 2024 for everybody, if willing to take a two-dose vaccine, to be vaccinated," Poonawalla said."It will be 2024 for everybody, if willing to take a two-dose vaccine, to be vaccinated," Poonawalla said.

Coronavirus: Oxford vaccine should be available for public by April 2021, to cost Rs 1,000: SII CEO

covid 19 vaccine update covid 19 vaccine india covid 19 vaccine latest update covid 19 vaccine update india covid 19 vaccine latest news covid 19 vaccine news covid 19 vaccine astrazeneca covid 19 vaccine availability covid 19 vaccine available in india covid 19 vaccine by india covid 19 vaccine by oxford university covid 19 vaccine by who covid 19 vaccine biotech covid 19 vaccine cost covid 19 vaccine covaxin covid 19 vaccine companies in india covid 19 vaccine covaxin update covid 19 vaccine distribution covid 19 vaccine distribution in india covid 19 vaccine development in india covid 19 vaccine date india covid 19 vaccine expected date covid 19 vaccine expected release covid 19 vaccine expected date in india covid 19 vaccine from indiaMeanwhile, the situation of COVID-19 remains grim in the national capital. The city recorded 7,546 fresh COVID-19 cases on Thursday, taking the infection tally to over 5.1 lakh.

When Will Oxford Vaccine be Available in India? How Much Will it Cost? Your Answers Here

While the search for a clinically approved vaccine continues to rage on in and around the world, the CEO of Serum Institute of India, Adar Poonawalla has said that the Oxford coronavirus vaccine should be available for the general public by April 2021. Many other companies working towards developing a vaccine have shown great progress.While the search for a clinically approved vaccine continues to rage on in and around the world, the CEO of Serum Institute of India, Adar Poonawalla has said that the Oxford coronavirus vaccine should be available for the general public by April 2021. Many other companies working towards developing a vaccine have shown great progress.

Coronavirus vaccine update: Serum Institute to deliver vaccine by April 2021 and other updates you need to do today | The Times of India

Access Denied

Oxford COVID-19 vaccine to be available by the year 2020 or early next year.Oxford COVID-19 vaccine to be available by the year 2020 or early next year.

Oxford COVID-19 Vaccine May Be Priced at Rs 500-600 Per Dose: SII CEO

As per Poonawalla, every Indian will get vaccinated probably by the end of 2024.As per Poonawalla, every Indian will get vaccinated probably by the end of 2024.

COVID-19 Vaccine Update: Oxford Vaccine To Be Available For Public By April Next Year | Price, Efficacy & All You Need To Know

Oxford covid vaccine | Speaking about the efficacy of the Oxford coronavirus vaccine, he said that the vaccine has so far proven to work well, even in elderly people, who are at a high risk of COVID-19. Oxford covid vaccine | Speaking about the efficacy of the Oxford coronavirus vaccine, he said that the vaccine has so far proven to work well, even in elderly people, who are at a high risk of COVID-19. 

Serum Institute of India’s CEO Adar Poonawalla said that the country could receive the Oxford COVID-19 vaccine for the frontline healthcare workers by the year 2020 or early next year. It will be priced at Rs 500-600 for two necessary doses.Serum Institute of India is planning to produce 100 million dosages of vaccines by February 2021.

Oxford COVID-19 Vaccine May be Priced at Rs 500-600: SII CEO

Asked about the efficacy of the vaccine, he said the Oxford-Astrazeneca vaccine is so far proving to work very well even in elderly people, which was a concern earlier.Asked about the efficacy of the vaccine, he said the Oxford-Astrazeneca vaccine is so far proving to work very well even in elderly people, which was a concern earlier.

Oxford COVID vaccine should be available for public by April 2021: Serum Institute CEO- The New Indian Express

India is racing ahead with work on its coronavirus vaccine as countries around the world sought to conquer the pandemic and rescue their economies.Also read: These three Indian companies are ready to produce Covid-19 vaccineIndia is racing ahead with work on its coronavirus vaccine as countries around the world sought to conquer the pandemic and rescue their economies.Also read: These three Indian companies are ready to produce Covid-19 vaccine

Oxford COVID-19 vaccine to be available for Indians by April 2021: Serum Institute Chief , World News | wionews.com

SII, which is the world's largest vaccine maker by volume, is trying to expand its capacity for manufacturing the vaccine to around 10 crore doses from around 5-6 crore doses now.Adar Poonawalla said if things go according to the plan, the coronavirus vaccine will be available for vulnerable populations by January or February. And, in March or April, the vaccine will enter the market for the general public

Oxford's coronavirus vaccine: Serum CEO Adar Poonawalla reveals price you'll have to pay

SII CEO Adar Poonawalla has said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February next yearSII CEO Adar Poonawalla has said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February next year

India could get Oxford Covid vaccine by Feb 2021; Rs 1000 for 2 doses: Serum's Poonawalla

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said that Oxford COVID-19 vaccine will be priced at a maximum of Rs 1,000 for two necessary doses for the public.

Oxford COVID-19 vaccine to be priced at Rs 1,000 for two doses: SII CEO Adar Poonawalla

New Delhi, November 20 Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by arouOxford-Astrazeneca vaccine is working well in elderly people, which was a concern earlier Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for

At Rs 1,000, India could get Covid vaccine by April next year, says Serum Institute CEO : The Tribune India

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderlyVaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly

COVID-19 vaccine will be priced at ₹1,000 and would be available by February for healthcare workers and elderly people, says Serum CEO Adar Poonawalla | Business Insider India

New Delhi: Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcareNew Delhi: Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare

Oxford COVID vaccine to be priced below 1k; likely available by Apr 2021

Probably by 2024, every Indian would get vaccinated, says the Serum Institute of India’s CEOProbably by 2024, every Indian would get vaccinated, says the Serum Institute of India’s CEO

Coronavirus | Oxford vaccine will cost ₹1,000, says Adar Poonawalla - The Hindu

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals.Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals.

Coronavirus: Oxford Vaccine Likely By April 2021, Rs 1,000 For 2 Doses: Adar Poonawalla Of Serum Institute of India

Probably by 2024, every Indian will get vaccinated, Serum Institute of India's CEO Adar Poonawalla saidProbably by 2024, every Indian will get vaccinated, Serum Institute of India's CEO Adar Poonawalla said

Covid Vaccine In Indian Market By April 2021; Rs 1,000 For Two Doses: Adar Poonawala

Serum Institute of India (SII) CEO Adar Poonawalla has said that the Oxford COVID-19 vaccine could be available in India by February 2021 for the healthcare workers and elderly people. He said that the common people could be inoculated by April. The vaccine will be priced a maximum Rs 1,000. ?If everything goes according to plan, January-February 2021 is our deadline for making the vaccine available to frontline workers and to the general public by March, April next year,? he said whileAdar Poonawalla said that the Oxford COVID19 vaccine could be available in India by February 2021. He said that common people will get the vaccine for a maximum of Rs 1,000. SII and ICMR have already completed enrolment process of 1,600 participants in the phase-III clinical trials for Covishield.

Oxford vaccine by February 2021, to be priced at Rs 1,000 in India, says Adar Poonawalla | India News – India TV